Klopfer; Kevin

Patent Applications and Registrations

Patent applications and USPTO patent grants for Klopfer; Kevin.The latest application filed is for "method of preparing oligonucleotide compounds".

Company Profile

1.8.11

Klopfer; Kevin - Flemington NJ

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method of Preparing Oligonucleotide Compounds App 20200392491 - Frank; Anthony ; et al.	2020-12-17
Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-(trans)-4-methoxycyclohexyl)-3- ,4-dihydropyrazino [2,3-b]pyrazin-2(1H)-one, a solid form thereof and methods of their use Grant 10,052,323 - Klopfer August 21, 2	2018-08-21
Pharmaceutical Compositions Of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-- 3,4-dihydropyrazino [2,3-b]pyrazin-2(1h)-one, A Solid Form Thereof And Methods Of Their Use App 20180200252 - KLOPFER; Kevin	2018-07-19
Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-- 3,4-dihydropyrazino[2,3- B]pyrazin-2(1H)-one, a solid form there of and methods of their use Grant 9,974,786 - Beauchamps , et al. May 22, 2	2018-05-22
Pharmaceutical Compositions Of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-- 3,4-dihydropyrazino [2,3-b]pyrazin-2(1h)-one, A Solid Form Thereof And Methods Of Their Use App 20180071287 - BEAUCHAMPS; Marie Georges ; et al.	2018-03-15
Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-- 3,4-dihydropyrazino [2,3-B]pyrazin-2(1H)-one, a solid form thereof and methods of their use Grant 9,795,603 - Beauchamps , et al. October 24, 2	2017-10-24
Solid forms comprising 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-- 3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one, and a coformer, compositions and methods of use thereof Grant 9,718,824 - Klopfer August 1, 2	2017-08-01
Pharmaceutical Compositions Of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-- 3,4-dihydropyrazino [2,3-b]pyrazin-2(1h)-one, A Solid Form Thereof And Methods Of Their Use App 20170182042 - BEAUCHAMPS; Marie Georges ; et al.	2017-06-29
Pharmaceutical compositions of 7-(6-(2-hydroxypropan-2-YL)pyridin-3-YL)-1-((trans)-4-methoxycyclohexyl)-- 3,4-dihydropyrazino [2,3-B]pyrazin-2(1H)-one, a solid form thereof and methods of their use Grant 9,604,939 - Beauchamps , et al. March 28, 2	2017-03-28
SOLID FORMS COMPRISING 7-(6-(2-HYDROXYPROPAN-2-YL)PYRIDIN-3-YL)-1-((TRANS)-4-METHOXYCYCLOHEXYL)-- 3,4-DIHYDROPYRAZINO[2,3-b]PYRAZIN-2(1H)-ONE, AND A COFORMER, COMPOSITIONS AND METHODS OF USE THEREOF App 20150299208 - KLOPFER; Kevin	2015-10-22
Pharmaceutical Compositions Of 7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-- 3,4-dihydropyrazino [2,3-b]pyrazin-2(1h)-one, A Solid Form Thereof And Methods Of Their Use App 20140356430 - BEAUCHAMPS; Marie Georges ; et al.	2014-12-04
Crystalline polymorphs of a CXC-chemokine receptor ligand Grant 8,207,221 - Hu , et al. June 26, 2	2012-06-26
Preparation of pharmaceutical salts of piperazine compounds Grant 7,521,452 - Wu , et al. April 21, 2	2009-04-21
Preparation Of Pharmaceutical Salts Of Piperazine Compounds App 20090093496 - Wu; Wenxue ; et al.	2009-04-09
Crystalline Polymorphs of a CXC-Chemokine Receptor Ligand App 20080279822 - Hu; Mengwei ; et al.	2008-11-13
Xanthine phosphodiesterase V inhibitor polymorphs Grant 7,192,962 - Dahanukar , et al. March 20, 2	2007-03-20
Preparation of pharmaceutical salts of piperazine compounds App 20060241295 - Wu; Wenxue ; et al.	2006-10-26
Crystalline polymorphs of a CXC-chemokine receptor ligand App 20050192345 - Hu, Mengwei ; et al.	2005-09-01
Xanthine phosphodiesterase V inhibitor polymorphs App 20030232845 - Dahanukar, Vilas H. ; et al.	2003-12-18

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.